BRIGHT MINDS BIOSCIENCES INC. - Common Shares (DRUG)
CUSIP: 10919W405
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Shares
- Shares outstanding
- 9,783,728
- Total 13F shares
- 5,234,387
- Share change
- +17,931
- Total reported value
- $136,973,710
- Price per share
- $26.11
- Number of holders
- 46
- Value change
- -$2,453,899
- Number of buys
- 28
- Number of sells
- 17
Quarterly Holders Quick Answers
What is CUSIP 10919W405?
CUSIP 10919W405 identifies DRUG - BRIGHT MINDS BIOSCIENCES INC. - Common Shares in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 10919W405:
Top shareholders of DRUG - BRIGHT MINDS BIOSCIENCES INC. - Common Shares (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
11%
|
1,111,368
|
$40,275,976 | — | 31 Mar 2025 | |
| Cormorant Asset Management, LP |
13F
|
Company |
11%
|
1,059,331
|
$38,210,069 | — | 31 Mar 2025 | |
| Sio Capital Management, LLC |
13F
|
Company |
5.2%
|
507,562
|
$18,307,761 | — | 31 Mar 2025 | |
| Commodore Capital LP |
13F
|
Company |
5.1%
|
500,000
|
$18,035,000 | — | 31 Mar 2025 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
4.5%
|
444,649
|
$16,038,489 | — | 31 Mar 2025 | |
| Vivo Capital, LLC |
13F
|
Company |
2.6%
|
251,572
|
$9,074,202 | — | 31 Mar 2025 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
13D/G
|
Company |
2.9%
from 13D/G
|
206,427
|
$7,445,822 | — | 31 Mar 2025 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
2%
|
200,000
|
$7,214,000 | — | 31 Mar 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
2%
|
192,557
|
$6,945,531 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1.6%
|
156,550
|
$5,646,759 | — | 31 Mar 2025 | |
| Point72 Asset Management, L.P. |
13F
13D/G
|
Company |
3%
from 13D/G
|
135,020
|
$4,870,171 | — | 31 Mar 2025 | |
| Walleye Capital LLC |
13F
|
Company |
0.87%
|
85,022
|
$3,066,744 | — | 31 Mar 2025 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.77%
|
75,601
|
$2,716,537 | — | 31 Mar 2025 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.67%
|
65,431
|
$2,360,097 | — | 31 Mar 2025 | |
| ACUTA CAPITAL PARTNERS, LLC |
13F
|
Company |
0.61%
|
59,748
|
$2,155,110 | — | 31 Mar 2025 | |
| PLATINUM INVESTMENT MANAGEMENT LTD |
13F
|
Company |
0.29%
|
28,308
|
$1,021,070 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.23%
|
22,222
|
$801,548 | — | 31 Mar 2025 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.2%
|
19,164
|
$691,245 | — | 31 Mar 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.19%
|
18,756
|
$676,529 | — | 31 Mar 2025 | |
| OMERS ADMINISTRATION Corp |
13F
|
Company |
0.14%
|
14,000
|
$504,980 | — | 31 Mar 2025 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.14%
|
13,568
|
$489,000 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.12%
|
11,535
|
$416,067 | — | 31 Mar 2025 | |
| AdvisorShares Investments LLC |
13F
|
Company |
0.12%
|
11,281
|
$407,357 | — | 31 Mar 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.07%
|
6,885
|
$248,342 | — | 31 Mar 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.07%
|
6,600
|
$238,062 | — | 31 Mar 2025 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
0.06%
|
5,963
|
$215,085 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.06%
|
5,416
|
$195,355 | — | 31 Mar 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.01%
|
1,100
|
$39,677 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0.01%
|
678
|
$24,455 | — | 31 Mar 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.01%
|
589
|
$21,000 | — | 31 Mar 2025 | |
| Caitong International Asset Management Co., Ltd |
13F
|
Company |
0%
|
140
|
$5,050 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
300
|
$2,394 | — | 31 Mar 2025 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0%
|
55
|
$1,984 | — | 31 Mar 2025 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
1
|
$36 | — | 31 Mar 2025 |
Institutional Holders of BRIGHT MINDS BIOSCIENCES INC. - Common Shares (DRUG) as of Q2 2025
As of 30 Jun 2025,
BRIGHT MINDS BIOSCIENCES INC. - Common Shares (DRUG) was held by
46 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,234,387 shares.
The largest 10 holders included
JANUS HENDERSON GROUP PLC, Cormorant Asset Management, LP, Sio Capital Management, LLC, Commodore Capital LP, PERCEPTIVE ADVISORS LLC, Vivo Capital, LLC, BlackRock, Inc., ADAGE CAPITAL PARTNERS GP, L.L.C., MORGAN STANLEY, and Point72 Asset Management, L.P..
This page lists
46
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
34
Q2 2025 holders
46
Holder diff
12
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.